Kovitz Investment Group Partners LLC Sells 1,705 Shares of Semler Scientific, Inc. (NASDAQ:SMLR)

Kovitz Investment Group Partners LLC decreased its holdings in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 7.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,384 shares of the company’s stock after selling 1,705 shares during the period. Kovitz Investment Group Partners LLC’s holdings in Semler Scientific were worth $527,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in SMLR. Cerity Partners LLC lifted its stake in Semler Scientific by 91.5% in the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock valued at $31,689,000 after buying an additional 642,982 shares during the period. Shariaportfolio Inc. acquired a new stake in Semler Scientific in the 3rd quarter valued at $3,618,000. AQR Capital Management LLC increased its position in shares of Semler Scientific by 150.1% during the second quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock worth $4,833,000 after acquiring an additional 84,314 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Semler Scientific by 18.3% in the second quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock worth $4,341,000 after purchasing an additional 19,552 shares during the last quarter. Finally, State Street Corp lifted its stake in Semler Scientific by 0.6% during the 3rd quarter. State Street Corp now owns 118,223 shares of the company’s stock valued at $2,784,000 after acquiring an additional 725 shares in the last quarter. Institutional investors own 49.37% of the company’s stock.

Semler Scientific Stock Performance

Semler Scientific stock opened at $71.84 on Friday. Semler Scientific, Inc. has a fifty-two week low of $20.88 and a fifty-two week high of $79.45. The firm’s 50-day simple moving average is $42.98 and its 200 day simple moving average is $34.45. The stock has a market cap of $595.48 million, a PE ratio of 35.04 and a beta of 1.18.

Semler Scientific (NASDAQ:SMLR) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The business had revenue of $13.51 million for the quarter.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.